Head, Katharine J.Hartsock, Jane A.Bakas, TamilynBoustani, Malaz A.Schroeder, MatthewFowler, Nicole R.2023-06-022023-06-022022-04-12Head KJ, Hartsock JA, Bakas T, Boustani MA, Schroeder M, Fowler NR. Development of Written Materials for Participants in an Alzheimer's Disease and Related Dementias Screening Trial. J Patient Exp. 2022;9:23743735221092573. Published 2022 Apr 12. doi:10.1177/23743735221092573https://hdl.handle.net/1805/33417Given that participants' experiences in clinical trials include a variety of communication touchpoints with clinical trial staff, these communications should be designed in a way that enhances the participant experience by paying attention to the self-determination theoretical concepts of competence, autonomy, and relatedness. In this feature, we argue that clinical trial teams need to consider the importance of how they design their written participant communication materials, and we explain in detail the process our multidisciplinary team took to design written materials for the patient and family caregiver participants in our Alzheimer's disease and related dementias (ADRD) screening trial. This article concludes with suggested guidance and steps for other clinical trial teams.en-USAttribution-NonCommercial 4.0 InternationalAlzheimer’s diseaseBest practicesCaregiversCommunicationDementiaFamilyScreeningSelf-determination theoryArticle